Literature DB >> 6835291

Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy.

M R Pudek, D W Seccombe, M F Whitfield, E Ling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6835291     DOI: 10.1056/nejm198304143081516

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 3.  Digitalis toxicity in infancy and childhood.

Authors:  S Singh
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

4.  Digitalis: where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1985-09

5.  Falsely raised plasma digoxin concentrations in liver disease.

Authors:  A A Nanji; D C Greenway
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-09

6.  Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.

Authors:  J M Bertrand; J P Langhendries; A Gras; O Battisti
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 7.  Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations.

Authors:  A D Mooradian
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

8.  Further evidence for the dissociation of digoxin-like immunoreactivity from Na+,K(+)-ATPase inhibitory activity.

Authors:  K Yamada; A Goto; M Ishii; M Yoshioka; T Sugimoto
Journal:  Experientia       Date:  1990-10-15

9.  Vasoconstrictor effects of endogenous digitalis-like factors extracted from urine of hypertensive patients.

Authors:  S Chiba; M Tsukada; Y Katsuyama; A Tada; H Zenda
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

10.  Digoxin-like substance in the serum of uremic patients before and after hemodialysis.

Authors:  Z Durakovic; D Ivanovic; A Durakovic
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.